Background parenchymal enhancement and uptake as breast cancer imaging biomarkers: A state-of-the-art review
E Bauer, MS Levy, L Domachevsky, D Anaby, N Nissan - Clinical Imaging, 2022 - Elsevier
Within the past decade, background parenchymal enhancement (BPE) and background
parenchymal uptake (BPU) have emerged as novel imaging-derived biomarkers in the …
parenchymal uptake (BPU) have emerged as novel imaging-derived biomarkers in the …
Background parenchymal enhancement and breast cancer: a review of the emerging evidences about its potential use as imaging biomarker
R Rella, A Contegiacomo, E Bufi… - The British Journal of …, 2021 - academic.oup.com
Objectives: To conduct a systematic review of evidences about the relationship between
background parenchymal enhancement (BPE) of the contralateral healthy breast and breast …
background parenchymal enhancement (BPE) of the contralateral healthy breast and breast …
Background parenchymal enhancement on breast MRI: a comprehensive review
GJ Liao, LC Henze Bancroft, RM Strigel… - Journal of Magnetic …, 2020 - Wiley Online Library
The degree of normal fibroglandular tissue that enhances on breast MRI, known as
background parenchymal enhancement (BPE), was initially described as an incidental …
background parenchymal enhancement (BPE), was initially described as an incidental …
[HTML][HTML] Quantitative background parenchymal uptake on molecular breast imaging and breast cancer risk: a case-control study
CB Hruska, JR Geske, TN Swanson, AN Mammel… - Breast Cancer …, 2018 - Springer
Background Background parenchymal uptake (BPU), which refers to the level of Tc-99m
sestamibi uptake within normal fibroglandular tissue on molecular breast imaging (MBI), has …
sestamibi uptake within normal fibroglandular tissue on molecular breast imaging (MBI), has …
[HTML][HTML] Background parenchymal uptake on molecular breast imaging as a breast cancer risk factor: a case-control study
CB Hruska, CG Scott, AL Conners, DH Whaley… - Breast Cancer …, 2016 - Springer
Background Molecular breast imaging (MBI) is a functional test used for supplemental
screening of women with mammographically dense breasts. Additionally, MBI depicts …
screening of women with mammographically dense breasts. Additionally, MBI depicts …
[HTML][HTML] Quantitative background parenchymal enhancement to predict recurrence after neoadjuvant chemotherapy for breast cancer
Breast background parenchymal enhancement (BPE) is an increasingly studied MRI
parameter that reflects the microvasculature of normal breast tissue, which has been shown …
parameter that reflects the microvasculature of normal breast tissue, which has been shown …
Quantitative assessment of breast parenchymal uptake on 18F-FDG PET/CT: correlation with age, background parenchymal enhancement, and amount of …
D Leithner, PA Baltzer… - Journal of Nuclear …, 2016 - Soc Nuclear Med
Background parenchymal enhancement (BPE), and the amount of fibroglandular tissue
(FGT) assessed with MRI have been implicated as sensitive imaging biomarkers for breast …
(FGT) assessed with MRI have been implicated as sensitive imaging biomarkers for breast …
[HTML][HTML] Background parenchymal enhancement in breast magnetic resonance imaging: a review of current evidences and future trends
R Rella, E Bufi, P Belli, A Contegiacomo… - Diagnostic and …, 2018 - Elsevier
Background parenchymal enhancement (BPE) on breast magnetic resonance imaging
(MRI) is a dynamic process, which varies among women and within the same woman over …
(MRI) is a dynamic process, which varies among women and within the same woman over …
[HTML][HTML] Association between background parenchymal enhancement and tumor response in patients with breast cancer receiving neoadjuvant chemotherapy
R Rella, E Bufi, P Belli, F Petta, T Serra… - Diagnostic and …, 2020 - Elsevier
Purpose To analyze the relationships between background parenchymal enhancement
(BPE) of the contralateral healthy breast and tumor response after neoadjuvant …
(BPE) of the contralateral healthy breast and tumor response after neoadjuvant …
Relationship between background parenchymal enhancement on breast MRI and pathological tumor response in breast cancer patients receiving neoadjuvant …
SJ Oh, EY Chae, JH Cha, HJ Shin… - The British Journal of …, 2018 - academic.oup.com
Objective: To evaluate the impact of background parenchymal enhancement (BPE) on
breast MRI and pathological tumor responses to neoadjuvant chemotherapy (NAC) in breast …
breast MRI and pathological tumor responses to neoadjuvant chemotherapy (NAC) in breast …